Vita 34 AG
XETRA:V3V
Vita 34 AG
Operating Income
Vita 34 AG
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita 34 AG
XETRA:V3V
|
Operating Income
-€22.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Operating Income
€1.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-3%
|
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Operating Income
€1.2B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-9%
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Operating Income
HK$194.1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
Synlab AG
XETRA:SYAB
|
Operating Income
€104.7m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Operating Income?
Operating Income
-22.1m
EUR
Based on the financial report for Sep 30, 2023, Vita 34 AG's Operating Income amounts to -22.1m EUR.
What is Vita 34 AG's Operating Income growth rate?
Operating Income CAGR 1Y
-41%
Over the last year, the Operating Income growth was -41%.